AIM
UTMD icon

Alambic Investment Management’s Utah Medical Products UTMD Stock Holding History

Alambic Investment Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,300
Closed -$206K – 585
2016
Q1 		$206K Buy
+3,300
New +$195K 0.07% 396

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Alambic Investment Management's UTMD Position: Q2 2016 in Review

Alambic Investment Management sold out of Utah Medical Products (UTMD) in Q2 2016, closing a stake of 3,300 shares — an estimated $206K sold.

Alambic Investment Management first reported a position in UTMD in Q1 2016 and held it in 1 quarter. The position peaked at $206K in Q1 2016. 76 funds tracked by Wall St. Rank hold UTMD as of Q2 2016.

  • Alambic Investment Management reported no remaining Utah Medical Products position as of Q2 2016 after selling out during the quarter.
  • Alambic Investment Management sold 3,300 Utah Medical Products shares in Q2 2016, an estimated $206K.
  • Alambic Investment Management first reported a position in Utah Medical Products in Q1 2016 and held it in 1 quarter.
  • Alambic Investment Management's Utah Medical Products position peaked at $206K in Q1 2016.
  • 76 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2016.

Based on Alambic Investment Management's 13F filing for Q2 2016, filed 8 Aug 2016.